Strelia advised Newton Biocapital on the deal.Newton Biocapital acted as lead investor in the 20 million series A investment round in NeuVasQ Biotechnologies, a spin-off of the…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now